Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

N2 Biomedical Receives NIH Grant to Develop Antimicrobial Biodegradable Bone Graft for Craniofacial Applications

N2 Biomedical received a Small Business Innovation Research Phase I grant from the National Institute of Dental & Craniofacial Research, to investigate a new antimicrobial biodegradable bone graft material. The Phase I study will develop a new biodegradable metallic material plus coating system to provide longer-term antibiotic delivery to the local environment. (Source: N2 Biomedical LLC)